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Abstract
Campylobacter and Salmonella are the most commonly reported bacterial causes of human foodborne infections, and increasing proportions
of these pathogens become resistant to medically important antimicrobial agents, imposing a burden on public health. Acquisition of resistance
to antibiotics affects the adaptation and evolution of Salmonella and Campylobacter in various environments. Many resistance-conferring mu-
tations entail a biological fitness cost, while others (e.g. fluoroquinolone resistance in Campylobacter) have no cost or even enhanced fitness. In
Salmonella, the fitness disadvantage due to antimicrobial resistance can be restored by acquired compensatory mutations, which occur both in
vitro and in vivo. The compensated or even enhanced fitness associated with antibiotic resistance may facilitate the spread and persistence
of antimicrobial-resistant Salmonella and Campylobacter in the absence of selection pressure, creating a significant barrier for controlling
antibiotic-resistant foodborne pathogens.
 2006 Elsevier SAS. All rights reserved.
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1. Introduction
In general, bacterial resistance to antimicrobials occurs via
either mutations in chromosomal loci or acquisition of hori-
zontally transferred mobile genetic elements such as plasmids,
phages, transposons and integrons [1e3]. The majority of the
metabolic elements targeted by antimicrobials (e.g. the ribo-
some, DNA gyrase, RNA polymerase, and cell wall, etc.)
are essential for bacterial growth. Therefore, genetic changes
(mutations) in these genes that are associated with antibiotic
resistance often have deleterious effects on the vital physiolog-
ical processes in microorganisms [1e3]. As a result, acquisi-
tion of drug resistance, particularly the resistance mediated
by chromosomal mutations, may incur a fitness cost in bacteria
in the absence of antibiotic selection pressure [4e9]. Resis-
tance acquired by horizontal gene transfer is thought to confer
a competitive growth disadvantage to the cell by imposing ad-
ditional energy expenditures that are needed to copy and tran-
scribe plasmid replicons. ‘Fitness cost’ is defined as reduced
growth and persistence of resistant bacteria in the host and en-
vironment or increased clearance from infected host and re-
duced transmission between hosts, and is typically measured
via laboratory experiments in culture media or animal models
[4,7,10]. However, compensatory mutations that partly or fully
ameliorate the fitness cost associated with acquisition of anti-
microbial resistance frequently occur in bacteria [5,7,11,12].
In addition, some resistance-conferring mutations bear ‘low-
cost’ or ‘no-cost’ or even enhanced fitness [8,13e23]. As a
result of both no-cost/low-cost mutations and compensatory
evolution, antimicrobial-resistant bacteria are able to stabilize
and persist in environments even in the absence of antibiotic
usage [3,6,17e19,24,25].
Among bacterial pathogens, Campylobacter and Salmo-
nella are the leading causes of human foodborne illnesses in
the developed countries. Both Campylobacter and Salmonella
are primarily intestinal organisms of a wide range of animals
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and are commonly present in the environment of food-produc-
ing animals [26,27]. In the last decades, Campylobacter and
Salmonella have developed resistance to many clinically im-
portant antimicrobials, including fluoroquinolones (FQ)
[28e32]. Although a large body of scientific information is
available on the prevalence of antimicrobial resistance and
its associated mechanisms in Salmonella and Campylobacter,
many aspects related to persistence and dissemination of the
antibiotic-resistant pathogens remain uncertain. Their trans-
mission and spread are not only affected by the environmental
and host factors, but also are influenced by the relative fitness
of the drug-resistant organisms in the absence of selection
pressure. In this paper we will review the recent literature on
the fitness changes associated with antimicrobial resistance
in Campylobacter and Salmonella and discuss the impact of
the fitness changes on the control of the foodborne pathogens.
2. Fitness of antibiotic-resistant Salmonella
Many studies have been performed to determine the effect
of resistance to streptomycin, fusidic acid, nalidixic acid, and
rifampicin on the biological fitness of Salmonella [13,33e36].
A general finding from these studies is that the resistance mu-
tations, at least initially, usually confer a fitness cost on Salmo-
nella since these mutants were outcompeted by their wild-type
strains in both culture media and animal models [6,7,13,35].
For example, fusidic acid resistance conferred by mutations
in the fusA gene (encoding elongation factor G [EF-G]) and
streptomycin resistance mediated by mutations in the rpsL
gene (encoding ribosomal protein S12) resulted in reduced
growth (in artificial growth medium and mice) of Salmonella
due to a decrease in the rate of protein synthesis [34,35]. Fur-
ther study indicated that the basal level (during steady-state
growth) and the induced level (during starvation) of ppGpp,
a global regulator for gene expression, were altered in fusidic
acid-resistant Salmonella mutants, leading to an abnormal
growth rate and cell size [37]. Since ppGpp positively regu-
lates rpoS, fusidic acid-resistant Salmonella mutants also
showed reduced ability to produce RpoS in the stationary
phase [38]. RpoS is a global regulator for general stress re-
sponse and an important virulence factor in Salmonella; and
the reduced induction of RpoS in the fusidic acid-resistant mu-
tants contributed to their low fitness in vivo [38]. In addition,
fusidic acid-resistant Salmonella mutants were hypersensitive
to oxidative stress, which was shown to be due to the reduced
transcription of hemA, encoding an enzyme involved in the
biosynthesis of heme [39]. Since heme is a cofactor for cata-
lase, the reduced level of heme in the fusidic acid-resistant
mutants impairs the function of catalases, resulting in hyper-
sensitivity to oxidative stress [39].
The degree of fitness cost varies dramatically among differ-
ent types of mutations that are associated with resistance to
various antibiotics [13,35]. Although the majority of the muta-
tions associated with resistance to streptomycin, fusidic acid,
nalidixic acid, and rifampicin incur a fitness loss in mice,
some of them did not show apparent growth disadvantage. For
example, a streptomycin-resistant mutant carrying a mutation
that alters AAA codon at position 42 to AGA in the rpsL
gene (K42T change in the corresponding protein) was fully
virulent in mice [13]. In addition, the initial fitness cost of
antimicrobial resistance mutations can be partly or fully
restored by compensatory mutations without loss of resis-
tance in Salmonella [2,13,35]. The extent to which fitness
was restored without loss of resistance varied dramatically
and seemed to be dependent on the specific resistance pheno-
type. For resistance to streptomycin, nalidixic acid, and to
a lesser degree rifampicin, most of the compensated mutants
restored fitness in mice and in laboratory medium to wild-
type or near wild-type levels, and some of the evolved
mutants exhibited fitness qualities superior to that of the
wild-type strains [13,35]. On the other hand, the relative fitness
of the majority of fusidic acid-resistant Salmonella isolates in
mice (but not in the culture medium) was substantially
decreased even after compensatory evolution took place [35].
The types of compensatory mutations that restore fitness
can be influenced by the environment in which the compensa-
tory mutations are formed and selected. It was shown by
Bjorkman et al. [35] that all streptomycin-resistant Salmonella
isolates that were compensated in vitro accumulated extra-
genic compensatory mutations in the rpsD and rpsE genes,
whereas when compensated in mice, they all contained intra-
genic suppressor mutations in the rpsL gene. On the other
hand, for fusidic acid resistance, 26 of the 28 compensated
mutants obtained in culture media had intragenic suppressor
mutations in the fusA gene, and the other two mutants had
true reversion to the susceptible genotype. In mice, the major-
ity (14/25) of the compensated mutants were true revertants
and the rest (11/25) of them were compensated by intragenic
suppressor mutations. Both the true revertants and compen-
sated mutants fully restored the fitness in the culture medium.
However, only the true revertants were fully fit in mice, with
the majority of the compensated mutants showing substan-
tially reduced fitness in the mouse model. The different spectra
of fusidic acid resistance compensatory mutations were thus
likely caused by differences either in the rate of mutation for-
mation or in the selective environment [35]. Because compen-
satory mutations can occur in multiple gene targets, the
mutation rate for compensation is higher than that for rever-
sion. Thus, compensatory mutations are usually more common
than true reversion [7].
Compensatory mutations are deleterious to the evolved
organisms when they are separated from the resistance-
conferring mutations. For example, most extragenic compensa-
torymutations of streptomycin resistance alone, when separated
from the resistance-conferring mutations in the compensated
mutants or when introduced into the antibiotic susceptible
wild-type background, incur a fitness cost on Salmonella
[13,34,35]. From the view point of evolution, compensatory
mutations must co-exist with resistance-associated mutations
for fitness restoration. Thus, once a resistance-conferring muta-
tion is acquired by pathogens, it may be difficult to revert it if
compensatory mutations have already occurred, because the
reversion to susceptibility without concomitant reverting of
compensatory mutations will make the pathogen unfit [6].
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How compensatory mutations restore the fitness deficit of
antibiotic-resistant Salmonella is still not well understood in
the majority of the cases. Fusidic acid inhibits protein synthe-
sis rate by binding to EF-G$GDP and blocking its release from
the ribosome [36]. Resistance to fusidic acid in Salmonella is
mediated by mutation in fusA, the gene encoding EF-G. The
resistance-associated mutations in EF-G decrease the rate of nu-
cleotide exchange (GDP-to-GTP) and reduce the rate of protein
synthesis [37]. In one study, 18 different types of intragenic
compensatory mutations in EF-G were observed, correcting
the fitness deficit fully or partly, probably by promoting the
transition of EF-G from a GDP-binding state to a GTP-
binding state [36]. Streptomycin binds to the ribosome and
inhibits the elongation step in protein synthesis. Bacterial
resistance to streptomycin is often mediated by mutations in
ribosomal protein S12 encoded by rpsL. In streptomycin-
resistant Salmonella due to restrictive mutations (increasing
proofreading and decreasing the rate of protein synthesis) in
S12, 35 different compensatory mutations that partly restored
the fitness were identified in S4, S5, S12, and L19 [33].
Many of the compensatory mutations occurred in the interface
between S4 and S5, and some of the mutations replaced
the charged residues at the interface [33]. These changes
presumably decrease translation fidelity and offset the over-
increased rate of proofreading occurring in streptomycin-
resistant mutants, thereby restoring the normal rate of protein
synthesis [33].
A few reports documented the effect of resistance to clini-
cally relevant antibiotics on the fitness of Salmonella. Highly
fluoroquinolone-resistant mutants of Salmonella Typhimurium
selected in vitro exhibited drastically altered growth character-
istic on solid media (smaller colony size) [40]. Further exper-
iments indicated that FQ-resistant (FQR) mutants selected in
vitro or in vivo (chicken) varied dramatically in the level of re-
sistance to FQ and the growth characteristics in culture me-
dium and in chickens in the absence of FQ antimicrobials
[41]. The in vitro selected mutants were highly resistant to
FQs, showed significantly reduced growth rate in culture me-
dium, and could not colonize chickens. In contrast, the in vivo
selected resistant isolates exhibited intermediate susceptibility
to FQs, had normal growth in liquid medium (slow growth on
solid medium), and were able to colonize chickens at the ex-
tent comparable to or lower than that of the wild-type strains.
After in vitro or in vivo passage in the absence of antibiotic
selective pressure, partial restoration of the fitness was ob-
tained without loss of the gyrA mutations [41]. Chromoso-
mally encoded AmpC beta-lactamases have not been
reported in Salmonella [9,11,42]. Artificial introduction of
ampC from Enterobacter cloacae into Salmonella enterica se-
rotype Typhimurium reduced its growth rate in culture media
and its invasiveness to MDCK cells [42]. However, when
ampC is co-transferred with ampR, which encodes a repressor
for AmpC, the fitness cost associated with ampC production
was eliminated, suggesting that the overexpression of ampC
was deleterious to Salmonella. Recently, Hossain et al. [11] as-
sessed the fitness of a clinical isolate of Salmonella shown to
produce several beta-lactamases including a plasmid-encoded
blaCMY-7 AmpC beta-lactamase. Both the clinical isolate and
a Salmonella transconjugant bearing the blaCMY-7 plasmid
were fully competent in culture medium and invasion of cul-
tured mammalian cells, while a Salmonella transformant ex-
pressing the cloned blaCMY-7 alone was deficient in both
growth rate and invasion of mammalian cells. This finding
suggested that the fitness cost associated with high-level pro-
duction of AmpC beta-lactamases in Salmonella may be com-
pensated by plasmid-encoded functions [11]. The recent
emergence of Salmonella populations resistant to extended-
spectrum cephalosporins in clinical setting and animal reser-
voirs [32,43e45] further suggests that Salmonella has evolved
mechanisms to compensate the loss of fitness associated with
resistance to beta-lactams.
Resistance-conferring mutations as well as compensatory
mutations occur frequently in bacteria exhibiting a mutator
phenotype [46]. However, a permanent mutator phenotype ac-
cumulates more deleterious mutations than non-mutators and
often shows a fitness disadvantage. As indicated by Chopra
et al., the fitness disadvantage may be compensated by the
high bacterial cell densities and the adoption of transient
mutator status [46]. Mutators can be found in the natural po-
pulations of Salmonella and presence of mutator strains is
considered a significant factor in the evolution of antibiotic-
resistant Salmonella [47,48].
Salmonella infections caused by antibiotic-resistant isolates
have been associated with increased risk of invasive illness,
hospitalization and longer duration of illness compared with
infections due to susceptible isolates [44,49e51]. It is difficult
to ascertain if this seemingly increased severity of drug-resis-
tant Salmonella infections is related to increased virulence of
resistant isolates, or poor response to antibiotic treatment. Car-
riage of both resistance determinants and virulence genes on
the same mobile element may enable some drug-resistant Sal-
monella isolates to be more virulent than drug susceptible
strains [43,52,53]. A particular concern is with multi-resistant
Salmonella Typhimurium definitive type 104 (mrDT104).
mrDT104 has disseminated globally in humans and animals
[29,32,54] and is associated with increased severity of clinical
illnesses [43,50,51,55]. However, experimental systems failed
to demonstrate enhanced virulence in mrDT104 isolates [56].
The effect of drug resistance determinants on the dissemina-
tion and virulence of mrDT104 is still questionable, and the
genetic traits that are responsible for the virulence and global
dissemination of mrDT104 remain to be elucidated [54].
3. Fitness of antibiotic-resistant Campylobacter
Unlike Salmonella, limited information is known about the
effect of antimicrobial resistance on the ecological fitness of
Campylobacter. Recently Luo et al. examined the persistence
and biological fitness of FQR Campylobacter in chicken, a nat-
ural host for Campylobacter, in the absence of antibiotic selec-
tion pressure by using clonally related isolates and genetically
definedmutants [23]. Several interesting findings were obtained
from this study. When monoinoculated into the chickens, FQR
Campylobacter was able to colonize and persist in chickens as
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efficiently as the FQ-susceptible (FQS) strains in the absence of
antibiotic usage. The prolonged colonization in vivo did not re-
sult in the reversion or loss of the specific resistance-conferring
mutation (C257T, leading to a Thr86Ile substitution in the GyrA
subunit) in gyrA. Surprisingly, when coinoculated into
chickens, the FQR Campylobacter outcompeted the FQS parent
strain and quickly became the dominant population in the
chicken host. When a series of clonally related FQR and FQS
isolates derived from chickens [57] were used in pairwise com-
petition in chickens, the FQR Campylobacter outcompeted the
majority of FQS strains. Notably, the fitness change in
FQR Campylobacter isolates could not be explained by
compensatory mutations because no mutations other than the
resistance-conferring C257T mutation were detected in the
gyrA and gyrB genes of the FQR strains. By using isogenic
mutants generated via natural transformation, the fitness change
was directly linked to the C257T mutation in gyrA, which
confers high-level resistance to FQ antimicrobials in Campylo-
bacter [23].
How the gyrA mutation affects Campylobacter fitness is
still unknown. Since DNA gyrase is important for DNA super-
coiling, the resistance-conferring mutation (C257T) in gyrA
may affect the supercoiling activity of the mutant enzyme
and consequently modulate the gene expression in Campylo-
bacter. This possibility is being examined in the laboratory
systems (Zhang, unpublished study). One interesting observa-
tion by Luo et al. [23] is that the same C257T mutation in gyrA
can also incur a fitness cost in a small number of isolates. This
finding suggests that when the C257T mutation is introduced
to different genetic backgrounds, it can either enhance or re-
duce the fitness of FQR Campylobacter. How the gyrA muta-
tion interacts with other genes in modulating Campylobacter
fitness remains to be examined in future studies.
To determine the physiological traits that are associated
with the enhanced fitness, FQR isolates were compared with
the isogenic FQS strains using various in vitro assays [23].
When separately cultured in antibiotic-free laboratory media,
FQR Campylobacter did not show any growth defect or en-
hancement compared to clonally related or isogenic FQS iso-
lates, in agreement with an early observation made with
a spontaneous FQR mutant selected in vitro [58]. The motility
(an important factor in chicken colonization) of FQR Campylo-
bacter was comparable with that of FQS strains. In addition,
the expression level of the multidrug efflux pump CmeABC,
which is essential for Campylobacter colonization in intestinal
tract by mediating bile resistance [59], was also the same be-
tween the FQR and FQS strains. These observations indicated
that the fitness change associated with FQ resistance cannot be
explained by the phenotypes measured using the in vitro as-
says. In vivo studies may be required to define the physio-
logical basis responsible for the fitness change of FQR
Campylobacter in chickens.
The laboratory observations made with FQR Campylobac-
ter are supported by findings from two epidemiological studies
[60,61]. A recent work by Price et al. revealed that FQR Cam-
pylobacter was still prevalent in chickens from farms that had
not used FQ antimicrobials for at least 1 year, indicating that
the FQR Campylobacter was able to persist in the farms even
in the absence of FQ usage [60]. Similarly, Pedersen and
Wedderkopp found that FQR Campylobacter still existed in
farms that had stopped using FQ for 4 years. PFGE analysis
of the isolates indicated that some FQR Campylobacter clones
were able to persist for several rotations on the farms in the
absence of FQ usage, suggesting that these resistant clones
were ecologically competent in the farm environments [61].
These observations suggest that FQR Campylobacter, once
evolved, may continue to persist in chicken flocks regardless
of the use of FQ antimicrobials.
Several studies reported that the human patients infected by
FQR Campylobacter had prolonged diarrhea, increased risk of
invasive illness, and hospitalization compared with patients
infected with FQS Campylobacter [12,62,63]. Whether the
increased clinical severity was related to enhanced virulence
of FQR Campylobacter or due to treatment failure is unknown.
In developed countries, human-to-human transmission of
Campylobacter is rare and campylobacteriosis is primarily
a foodborne disease. The fitness change associated with FQ re-
sistance would impact the persistence and prevalence of FQR
Campylobacter in animal reservoirs and eventually affect the
health of the human hosts.
Analysis of the genomic sequences [64,65] revealed that
Campylobacter lacks many genes encoding components of
DNA repair systems that are present in other bacteria. In par-
ticular, genes encoding the MutH and MutL components of the
methyl-directed mismatch repair are absent in Campylobacter
spp. This system seems to be also absent in the related Helico-
bacter pylori, explaining the high mutation rates observed in
this bacterium [66]. Campylobacter also lacks the LexA re-
pressor (involved in SOS response), the umuCD genes (UV-
induced mutagenesis), SbcB exodeoxyribonuclease I (recom-
bination repair), the vsr gene (very short patch repair), the
ada gene (adaptative response to alkylating agents), and the
phr gene (encoding photolyase enabling repair of pyrimidine
dimers by photoreactivation). These defects in the repair sys-
tems may contribute to the ability of Campylobacter to mutate
and acquire antibiotic resistance traits.
Although many Campylobacter strains are resistant to non-
FQ antibiotics, the effect of acquiring resistance to non-FQ an-
timicrobials on Campylobacter fitness is unknown and remains
to be investigated in future studies. Gibreel et al. [67] recently
demonstrated the stability of the macrolide resistance-confer-
ring mutations (except the A2074G mutation in 23S rRNA) by
repetitive subcultures. However, it is unknown if macrolide-re-
sistant Campylobacter can compete with macrolide-susceptible
strains in the absence ofmacrolide antibiotics. In the related bac-
teriumH. pylori, clarithromycin resistance appears to incur a bi-
ological cost [66]. A recent work by Luangtongkum et al. (T.
Luangtongkum, T.Y. Morishita, L. Martin, I. Choi, and Q.
Zhang. Abstract no. A55, 13th InternationalWorkshop onCam-
pylobacter, Helicobacter, and Related Organisms, Gold Coast,
Australia, September 4e8, 2005) revealed the high prevalence
and dynamic change in tetracycline-resistant Campylobacter
strains on organic poultry farms, where no antibiotics were
used for the production. It was found that tetracycline-resistant
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Campylobacter co-existed with or even replaced pre-existing
tetracycline-susceptible strains in the chicken flocks in the ab-
sence of antibiotic usage. The majority of the tetracycline-resis-
tant strains carried the tet(O) plasmid. In another study by
Avrain et al. [68] it was shown that the horizontal transfer of
the tet(O) gene could occur rapidly between Campylobacter je-
juni strains in the intestinal tract of chickens in the absence of
antibiotic selection pressure. Tetracycline-resistant Campylo-
bacter strains were also frequently isolated from organic dairy
farms [69]. Together, these findings suggest that tetracycline-re-
sistant Campylobacter has evolutionally adapted to the animal
production environment and may continue to persist on farms
regardless of the use of tetracycline antibiotics.
4. Concluding remarks
It is apparent that acquisition of antimicrobial resistance af-
fects the adaptation and evolution of Salmonella and Campylo-
bacter in various environments. Some resistance-conferring
mutations incur a fitness cost, while others have low or no
cost or even enhanced fitness in the absence of selection pres-
sure. Compensatory mutations that ameliorate fitness cost fre-
quently occur in Salmonella. These observations may help
explain the persistence of resistance phenotypes in modern iso-
lates to antimicrobials that are used rarely or not at all. The
types of compensatory mutations and the level of restoration
of fitness vary with the antibiotics to which the resistance-con-
ferring mutations are developed and the environment in which
the compensatory mutations are formed and selected. With
Campylobacter, both laboratory studies and epidemiological
surveys indicated that many FQR mutants are as competent as
or even more fit than FQS strains, which may partly explain
the increasing prevalence of FQR Campylobacter on a global
scale. Since antibiotic-resistant Salmonella and Campylobacter
may still retain fitness in the absence of antibiotic usage, reduc-
tion or discontinuation of antimicrobial use in the farm environ-
ment alone may not necessarily result in, at least in the short
term, a decrease in the frequency of antibiotic-resistant isolates.
Understanding how resistance-conferring mutations affect the
adaptation and evolution of microbial pathogens will facilitate
the development of means to predict and prevent transmission
of antibiotic-resistant foodborne pathogens.
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